PHARMA SIGNALOPEN RESEARCH PLATFORM →
COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

Alvotech SA

Biosimilar developer founded in Reykjavik, where its corporate headquarters, primary manufacturing site, and much of its R&D are located. The listed parent is incorporated in Luxembourg.

TICKERALVO
HEADQUARTERSReykjavik, Iceland
STAGENot specified
ACTIVE TRIALS

Therapeutic areas

Immunology

Selected products and programs

AVT05AVT02

Linked curated drug profiles

No curated drug entity is linked in the current pilot.

Selected active clinical trials

No active trial records are linked in the current company snapshot.

Selected patent records

No linked FDA Orange Book patent record was found for the selected products.

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier
/companies/alvotech-sa/
Event / action date
Not separately retained
Source update date
Not separately retained
Platform retrieval / processing date
Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record